Programming of fetal insulin resistance in pregnancies with maternal obesity by ER stress and inflammation
Author
dc.contributor.author
Westermeier, Francisco
Author
dc.contributor.author
Sáez, Pablo J.
Author
dc.contributor.author
Villalobos-Labra, Roberto
Author
dc.contributor.author
Sobrevia, Luis
Author
dc.contributor.author
Farías-Jofré, Marcelo
Admission date
dc.date.accessioned
2019-03-15T16:06:51Z
Available date
dc.date.available
2019-03-15T16:06:51Z
Publication date
dc.date.issued
2014
Cita de ítem
dc.identifier.citation
BioMed Research International, Volumen 2014,
Identifier
dc.identifier.issn
23146141
Identifier
dc.identifier.issn
23146133
Identifier
dc.identifier.other
10.1155/2014/917672
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/166222
Abstract
dc.description.abstract
The global epidemics of obesity during pregnancy and excessive gestational weight gain (GWG) are major public health problems worldwide. Obesity and excessive GWG are related to several maternal and fetal complications, including diabetes (pregestational and gestational diabetes) and intrauterine programming of insulin resistance (IR). Maternal obesity (MO) and neonatal IR are associated with long-term development of obesity, diabetes mellitus, and increased global cardiovascular risk in the offspring. Multiple mechanisms of insulin signaling pathway impairment have been described in obese individuals, involving complex interactions of chronically elevated inflammatory mediators, adipokines, and the critical role of the endoplasmic reticulum (ER) stress-dependent unfolded protein response (UPR). However, the underlying cellular processes linking MO and IR in the offspring have not been fully elucidated. Here, we summarize the state-of-the-art evidence supporting the possibility that ad